MARKET

VIVO

VIVO

Meridian Biosci
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.99
-0.14
-0.99%
After Hours: 13.75 -0.24 -1.69% 16:50 05/27 EDT
OPEN
14.00
PREV CLOSE
14.13
HIGH
14.19
LOW
13.19
VOLUME
1.30M
TURNOVER
--
52 WEEK HIGH
18.58
52 WEEK LOW
5.51
MARKET CAP
599.23M
P/E (TTM)
28.11
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average VIVO stock price target is 9.00 with a high estimate of 9.00 and a low estimate of 9.00.

EPS

VIVO News

More
Meridian Bioscience Promotes Tony Serafini-Lamanna to Executive Vice President of Diagnostics
GlobeNewswire · 05/20 21:20
Top Stock Picks for Week of May 11, 2020
Zacks · 05/12 21:20
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 70 companies set new 52-week highs.
Benzinga · 05/11 14:29
Stock market live updates: Dow falls 100, second wave fears
A conversation about the latest market-moving news, including new coronavirus cases being reported in Japan and Singapore.
CNBC.com · 05/11 11:34
Meridian Bioscience, Inc. (VIVO) CEO Jack Kenny on Q2 2020 Results-Earnings Call Transcript
Seeking Alpha - Transcript · 05/09 20:45
Edited Transcript of VIVO earnings conference call or presentation 8-May-20 2:00pm GMT
Thomson Reuters StreetEvents · 05/09 00:35
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 60 companies set new 52-week highs.
Benzinga · 05/08 14:32
Meridian Bioscience, Inc. 2020 Q2 - Results - Earnings Call Presentation
Seeking Alpha - Article · 05/08 14:08

Industry

Medical Equipment, Supplies & Distribution
+0.74%
Healthcare Equipment & Supplies
+0.73%

Hot Stocks

Symbol
Price
%Change

About VIVO

Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.
More

Webull offers kinds of Meridian Bioscience, Inc. stock information, including NASDAQ:VIVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVO stock news, and many more online research tools to help you make informed decisions.